Please use this identifier to cite or link to this item:
|Title:||The lipid droplet as a potential therapeutic target in NAFLD||Authors:||Goh, V.J.
nonalcoholic fatty liver disease
|Issue Date:||2013||Citation:||Goh, V.J., Silver, D.L. (2013). The lipid droplet as a potential therapeutic target in NAFLD. Seminars in Liver Disease 33 (4) : 312-320. ScholarBank@NUS Repository. https://doi.org/10.1055/s-0033-1358521||Abstract:||Nonalcoholic fatty liver disease (NAFLD) is a growing problem worldwide. Nonalcoholic fatty liver disease is characterized by an abnormal accumulation of triglyceride-rich lipid droplets (LDs) in the liver, which can lead to liver inflammation and metabolic disturbances. Lipid droplets are dynamic organelles that have recently gained considerable scientific interest. Their formation and growth are regulated processes requiring the participation of many endoplasmic reticulum- (ER-) and LD-associated proteins, which may serve as potential therapeutic targets for NAFLD. Protein families such as fat-inducing transmembrane proteins 1 and 2 (FITM1/FIT1 and FITM2/FIT2), the CIDE family of proteins, and the perilipin family, play important roles in LD biology. In this review, the authors discuss current views on LD formation and growth, and how various proteins may affect LD metabolism and lipoprotein assembly in the pathogenesis of NAFLD. © 2013 by Thieme Medical Publishers, Inc.||Source Title:||Seminars in Liver Disease||URI:||http://scholarbank.nus.edu.sg/handle/10635/128628||ISSN:||02728087||DOI:||10.1055/s-0033-1358521|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.